What is CureApp?
CureApp is at the forefront of revolutionizing healthcare treatment through advanced software solutions. The company develops evidence-based medical device programs and therapeutic applications designed to address conditions that are inadequately managed by traditional pharmaceuticals and hardware. By leveraging evolving technology, CureApp aims to improve patient outcomes and enhance the overall treatment experience. Their offerings include mobile health programs tailored for corporate wellness, promoting health management within the workplace. CureApp's digital therapies provide personalized interventions and support, extending care beyond conventional medical settings.
How much funding has CureApp raised?
CureApp has raised a total of $44.7M across 1 funding round:
Series G
$44.7M
Series G (2022): $44.7M with participation from Carlyle
Key Investors in CureApp
Carlyle
Carlyle is a global investment firm with a broad focus on private equity, venture, and growth capital. Their extensive experience in various markets suggests a strategic interest in companies poised for significant expansion and market impact, aligning with CureApp's mission in digital health.
What's next for CureApp?
The recent major strategic investment signifies a critical phase for CureApp, likely enabling the company to accelerate its research and development, expand its market reach, and further enhance its digital therapeutic platforms. This enterprise-level funding suggests a strong investor confidence in CureApp's business model and its potential to disrupt traditional healthcare paradigms. Future growth will likely involve broader clinical validation, strategic partnerships, and the scaling of its corporate wellness and patient-focused digital solutions.
See full CureApp company page
